account_balance
Investment manager · 13F filer · SEC CIK 1599882
Rhenman & Partners Asset Management AB
Reported value$903Mas of Sep 30, 2026
Positions93 15 new, 21 sold out
Top 10 weight30.0%IOVA alone is 4%
FiledNov 1243 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
New or addedTrimmedHeld
IOVAIovance Biotherapeutics, Inc.
4.1%Added +47%
AZNAstrazeneca PLC
3.4%Added +22%
MRKMerck & Co., Inc.
3.3%Trimmed −3%
MDTMedtronic PLC
3.2%Added +134%
UNHUnitedHealth Group Inc
2.9%Trimmed −24%
VRTXVertex Pharmaceuticals Inc
2.8%Added +59%
GILDGilead Sciences, Inc.
2.6%Trimmed −11%
EWEdwards Lifesciences Corp
2.6%Added +5%
BMRNBiomarin Pharmaceutical Inc
2.6%Added +33%
BIIBBiogen Inc.
2.4%Added +2%
LLYELI Lilly & Co
2.4%Trimmed −15%
INSMInsmed Inc
2.4%
IOVAIovance Biotherapeutics, Inc.
4.1%+47%
AZNAstrazeneca PLC
3.4%
MRKMerck & Co., Inc.
3.3%
MDTMedtronic PLC
3.2%+134%
UNHUnitedHealth Group Inc
2.9%−24%
VRTXVertex Pharmaceuticals Inc
2.8%+59%
GILDGilead Sciences, Inc.
2.6%
EWEdwards Lifesciences Corp
2.6%
BMRNBiomarin Pharmaceutical Inc
2.6%
BIIBBiogen Inc.
2.4%
LLYELI Lilly & Co
2.4%
INSMInsmed Inc
2.4%
Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
IOVA Iovance Biotherapeutics, Inc. 4.1% Added +47%AZN Astrazeneca PLC 3.4% Added +22%MRK Merck & Co., Inc. 3.3% Trimmed −3%MDT Medtronic PLC 3.2% Added +134%UNH UnitedHealth Group Inc 2.9% Trimmed −24%VRTX Vertex Pharmaceuticals Inc 2.8% Added +59%GILD Gilead Sciences, Inc. 2.6% Trimmed −11%EW Edwards Lifesciences Corp 2.6% Added +5%BMRN Biomarin Pharmaceutical Inc 2.6% Added +33%BIIB Biogen Inc. 2.4% Added +2%LLY ELI Lilly & Co 2.4% Trimmed −15%INSM Insmed Inc 2.4% Added +23%
What changed
Biggest moves since Jun 30, 2026
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.